Financial giants have made a conspicuous bullish move on Axsome Therapeutics. Our analysis of options history for Axsome Therapeutics AXSM revealed 8 unusual trades.
Delving into the details, we found 50% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $328,790, and 2 were calls, valued at $72,142.
Expected Price Movements
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $65.0 to $75.0 for Axsome Therapeutics during the past quarter.
Volume & Open Interest Trends
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Axsome Therapeutics's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Axsome Therapeutics's whale activity within a strike price range from $65.0 to $75.0 in the last 30 days.
Axsome Therapeutics Call and Put Volume: 30-Day Overview
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AXSM | PUT | SWEEP | BULLISH | 01/17/25 | $16.3 | $13.2 | $14.5 | $75.00 | $72.5K | 169 | 5 |
| AXSM | PUT | SWEEP | BEARISH | 06/21/24 | $4.4 | $4.3 | $4.4 | $67.50 | $66.0K | 711 | 202 |
| AXSM | PUT | SWEEP | BEARISH | 06/21/24 | $7.0 | $6.1 | $7.0 | $72.50 | $64.4K | 411 | 102 |
| AXSM | PUT | SWEEP | BULLISH | 06/21/24 | $4.6 | $2.5 | $2.5 | $65.00 | $53.0K | 640 | 263 |
| AXSM | CALL | SWEEP | BULLISH | 06/21/24 | $2.55 | $2.15 | $2.55 | $67.50 | $44.6K | 61 | 12 |
About Axsome Therapeutics
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
In light of the recent options history for Axsome Therapeutics, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Axsome Therapeutics's Current Market Status
- Currently trading with a volume of 2,859,818, the AXSM's price is down by -2.37%, now at $70.09.
- RSI readings suggest the stock is currently may be approaching oversold.
- Anticipated earnings release is in 55 days.
Professional Analyst Ratings for Axsome Therapeutics
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $160.0.
- An analyst from RBC Capital persists with their Outperform rating on Axsome Therapeutics, maintaining a target price of $130.
- Reflecting concerns, an analyst from HC Wainwright & Co. lowers its rating to Buy with a new price target of $190.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Axsome Therapeutics options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
